Time filter

Source Type

Delbos V.,University of Rouen | Lemee L.,University of Rouen | Benichou J.,University of Rouen | Benichou J.,French Institute of Health and Medical Research | And 18 more authors.
Vaccine | Year: 2013

The aim of the study was to analyze the impact of MenBvac, an outer membrane vesicle (OMV) vaccine against P1.7,16 strains, on meningococcal carriage. During a B:14:P1.7,16/ST-32 outbreak in Normandy (France), children aged 1-7 years were randomly selected to participate in the study. Among the 1082 volunteers, there were 17 Neisseria meningitidis carriers (carriage rate of 1.57%). MenBvac vaccination appeared associated with lower carriage rate, i.e., 0.31% among the vaccinated children versus 2.10% among the non-vaccinated ( p= 0.03). The beneficial effect on carriage was observed regardless of the strain serogroup. OMV-vaccinated mice also showed reduction of bacterial acquisition of OMV-homolog and hererolog strains in respiratory pathways after intranasal challenge. These results suggest that meningococcal OMV-based vaccines reduce meningococcal carriage and may hence confer herd immunity. © 2013 Elsevier Ltd.

Loading Center Hospitalier General deDieppe collaborators
Loading Center Hospitalier General deDieppe collaborators